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Tyrosinase (EC 1.14.18.1) is the enzyme essential to 
pigment formation in mammals; this enzyme is specifi-
cally localized in melanocytes, which occur primarily in 
the skin, hair bulbs, and eyes. Three hybridomas, TMH-
1, TMH-2, and TMH-3, which produce monoclonal an-
tibodies directed against tyrosinase, were obtained by 
fusion of SP2/0 myeloma cells and lymphocytes of rats 
hyperimmunized with purified melanosomal tyrosinase. 
These three monoclonal antibodies bound specifically to 
the mature, T • form of tyrosinase, and did not bind to 
either of the precursor forms (T 1 or T z) of the enzyme, 
which demonstrates that further posttranslational mod-
. ifications of this enzyme occur which had not previously 
been detected. Epitope mapping studies have shown that 
at least two different immunologic determinants on ty-
rosinase are recognized by these antibodies. All three 
antibodies showed positive immunofluorescence stain-
ing of pigmented murine melanocytes from various 
sources, including B16 melanoma growing in vivo and 
in vitro, epidermal melanocytes, and retinal melano-
cytes. The antibodies did not cross-react with unpig-
mented cells, including K1735 amelanotic melanoma 
cells, albino murine skin or eye tissue, fibrosarcoma 
cells, rat fibroblasts, or epidermal keratinocytes. These 
monoclonal antibodies are sensitive, highly specific 
probes for pigmented mammalian melanocytes. 
Tyrosinase (EC 1..14.18.1), the enzyme responsible for the 
formation of melanin pigment in animals, occurs in four dis-
tinct forms as identified by polyacrylamide gel electrophoresis 
[1- 6]. Tyrosinase bound to melanosomes where physiologic 
melanin formation takes place in the melanocyte is termed T 4 -
tyrosinase. The other three forms are named T.- , T 2-, and T:,-
tyrosinase in order of decreasing electrophoretic mobility, and 
appear to be precursors of the T, form of the enzyme. After 
solubi lization of the melanosomes using ionic detergents or 
trypsin, T,-tyrosinase shows the same electrophoretic mobility 
as T1-tyrosinase (6,7]. Tyrosinase has been shown to be a 
glycoprotein [6,8- 10], and the differences in electrophoretic 
mobil ity of the three forms are thought to be due to various 
amounts of sialic acid, man nose, and galactose which are bound 
to tyrosinase during its posttranslational processing [11]. No 
differences in immunologic determinants [12], enzyme kinetics, 
or amino acid composition among the four forms of tyrosinase 
had previously been demonstrated [6,12], nor have the physio-
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logic roles of those enzyme forms been elucidated yet. Poly -
clonal antibodies to various mammalian tyrosinases have been 
produced [13- 16), but the absolute specificities of these re-
agents have never been fully documented, nor have they been 
used for the identification of melanocytes by indirect immu-
nofluorescence. 
This present work set out to produce monoclonal antibodies 
which could specifically recognize each of the isozymic forms 
of tyrosinase; tyrosinase-specific monoclonal antibodies would 
prove to be extremely useful tools for the study of posttransla-
tional enzyme processing, and for many other aspects of the 
study of p igment cell biology. In addition, monoclonal antibod-
ies specific to tyrosinase should prove valuable to clinicians 
and researchers alike, to enable a sensitive, quick, and specific 
identification of melanocytes in vitro or in vivo; these are 
currently time-consuming, expensive, and difficult determina-
tions which require histochemical and electron microscopic 
procedures. Further , tyrosinase-specific monoclonal antibodies 
would be useful in the rapid identification by immunoassay of 
pigmented malignant melanoma cells, and in the reassessment 
of the role of tyrosinase in many pigmentary disorders, such as 
albinism and vitiligo. 
MATERIALS AND METHODS 
Materials 
Complete Freund's adjuvant was obtained from Difco Laboratories 
(Detroit, Michigan); sheep anti rat lgA, sheep antirat lgE, rabbit antirat 
lgG" goat antirat lgGz., sheep antirat lgG 2.,, goat antirat lgGz.,, and 
goat antirat lgM were from Pei-Freez Biologicals (Rogers, Arkansas); 
peroxidase- and fluorescein isothiocyanate (FITC)-conjugated rabbit 
lgG antirat immunoglobulins, and goat lgG antirabbit immunoglobu-
lins, were from Dako Corporation (Santa Barbara, California); Dulbec-
co's modified Eagle's medium (DMEM) and other tissue culture sup-
plies were from GIBCO Laboratories (Grand Island, New York); lm-
mulon 2 flat-bottom microelisa plates were from Dynatech Laboratories 
(Alexandria, Virginia); Staphylococcw; aureus V8 protease, Lab-Tek 
tissue culture chamber/slides, and O.C.T. embedding medium were 
from Miles Laboratories (Naperville, Illinois); lmmuno-Tec ll OT 
agarosP. plate kit was from Calbiochem Corporation (La Jolla, Califor-
nia). [35S]methionine (4000 Ci/mmol) and En"Hance were from New 
England Nuclear (Boston, Massachusetts) ; Protein A Sepharose was 
from Pharmacia, Inc. (Piscataway, New Jersey). Kl735 amelanotic 
melanoma cells and 112 fibrosarcoma cells were a gift from Dr. Douglas 
Gersten, Georgetown University Medical Center, Washington, D.C. 
Pathogen-free mice and rats used in this study were obtained through 
the Veterinary Resources Branch at N.I.H. 
Preparation of Tyrosinase 
T,- , Tz-, and 1\-tyrosinases were separated and purified as previously 
deta1led [6,17]; the purity of these immunizing fractions is shown in 
F1g 2A. The high-molecular-weight, aggregated form of tyrosinase 
bound to melanosomes was originally termed T,-tyrosinase, but 
throughout this paper, T,-tyrosinase refers to the form which has been 
solubilized by trypsinization [6,7]. 
Hybridorna Antibody Production 
In each experiment, 2 F344/N albino male rats were hyperimmunized 
with s.c. injections at multiple sites with tyrosinase (1 mg of protein) 
mixed with an equal volume (500 Ill) of complete Freund's adjuvant. 
The rats were given an i.p. booster injection of 200 lig of tyrosinase 
without adjuvant after 3 weeks. Three days after the booster dose, the 
spleen from the rat with the highest titer of antibody production was 
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aseptically removed for hybridizat ion, and hybridornas were derived by 
fusion of approx imate ly 109 SP2/0 myeloma cells wit h approximately 
2 x 108 spleen ce lls us ing polyethylene glyco l. T he SP2/ 0 myeloma 
cells were grown in medium composed of 83% DMEM conta ining 
penic illin (100 U/m l), streptomycin (100 U/m l), and Fungizone (0.25 
JLg/ ml) , glu tam ine, nonessent ial amino acids, and 17% feta l bovine 
serum . T he hybridization, screening and cloning procedures by limiting 
di lution were carried out using the method described by Oi and Her-
zenberg 118 ]; more t han 500 wells in each experiment were ini tia lly 
screened for specific ant ibody production. 
Enzyme-Linked lmmunosorbent Assay (EL ISA) 
The screening of antibody production in hybridomas was carr ied out 
using ELISA methodology as follows: Immulon 2 fl at-bottom plates 
were coated overnight at 4•c with 100 ng of protein in 50 ILl of 0.05 M 
carbonate-bicarbonate buffer (pH 9.6) containing 0.2 mg/ ml sodium 
azide. The plates were washed 6 t imes with 0.01 M phosphate-buffered 
saline (PBS) (pH 7.2), 0.8% NaCl, and 0.05 % Tween-20 (PBS/ Tween), 
a fte r which 50 1d of spent medium was added to each well. After 1 h at 
room temperature, the we lls were washed 6 times with PBS/Tween, 
t hen 50 J.Ll of peroxidase-conjugated rabbit ant irat immunoglobulins in 
PBS (1:1000) was washed 6 times with PBS/Tween , t hen 100 J.Ll of a-
phenylenediamine solution (I mg/ml) containing 0.012 % hydrogen 
peroxide in 0. 1 M cit rate buffer (pH 4.5) was added to each well. The 
peroxidase reaction was stopped by t he addition of 100 J.Ll of 2 N sulfuric 
ac id and the absorbance was measured at 492 nm in a Labtek Multi-
s ka n. 
When t he determination of rat immunoglobulin subclass of mono-
clona l antibody was ca rried out, t he ELISA method was a lso ut ilized. 
In t his instance, 12- 300 ng each of sheep, rabbit, or goat ant ibodies 
aga inst rat JgA, lgE, lgG, , JgG 28 , JgG,n, IgG2~ , and lgM were bound to 
t he wells of the plates as above. After washmg, monoclonal antibody 
s upernatants were added to t he we lls and incubated for 1 h, and the 
assay was cont inued as deta iled above. The Ouchterlony technique was 
a lso used fo r the determinat ion of rat immunoglobulin subclass of the 
monoclonal ant ibodies by using a Calbiochem lmmuno-Tec Il OT 
agarose plate ki t. 
A ntibody Spec1ji.city Analysis 
T his was carried out using the Western immunoblot technique in 
t he following manner: electrophoretic separation of tyrosinases was 
performed as previously described, in 7.5% polyacry la mide gels [6]. 
Proteins were electrophoretically t ransferred from t he polyacrylamide 
gels to nitrocellulose sheets by the method of T owbin et al [19] in 25 
mM potass ium phosphate buffer (pH 6.5) at 15 V overnight. Afte r 
t ransfer, one sheet (panel B in Fig 1) was stained with 0.1% dopa {1-
3 ,4 -dihydroxyphenyla lanine) in 0.1 M phosphate buffer, pH 7.2, for 
visualization of enzyme activity, and t he others (panels A, C, D, and E 
in Fig 1) were stained with 0.01 % fast green in 10% acetic acid, 5% 
methanol for visua lization of proteins and to enable accurate cutting 
o f t he ni t rocellulose sheets. The sheets were t hen incubated in a mix ture 
of PBS, 0.1 % NP-40, and 2% bovine serum albumi n (PBS/NP-40/ 
BSA) at 37•c for 2 h to saturate the remaining free absorption s ites. 
After washing 5 t imes wi th PBS/NP-40 (during which t ime t he fast 
green dye is eluted) , t he sheets were incubated with 2 ml of monoclonal 
a ntibody supernatants as noted in Figs 1 and 4, di luted to lO ml with 
PBS/NP-40, at room temperature for 2 h. Afte r washing again 5 t imes 
with t he PBS/ NP-40, the sheets were fina lly incubated for 2 h at room 
temperature with peroxidase-conjugated rabbit ant irat immunoglobu-
lins in PBS/ NP-40 (3:1000). After washing 5 times with the PBS/ NP-
40 t he sheets were incubated in 0.1 mg/ml of 3,3 ' -diaminobenzidine, 
0.01% hydrogen peroxide in PBS. The reaction was te rminated after 
incubation by washing wi th water, and t he sheets were dried and stored 
at 4•C un t il photographed. 
Specificity of the ant ibodies was also determined by indirect immu -
nofluorescent staining by the method of Stanley et a l [20 ]; ce lls ex-
amined included the B16 melanoma, K1735 amelanotic melanoma, 112 
fibrosarcoma, rat fi broblasts, and tissues from 5-day newborn black 
(C57B1/6N) and 5-day newborn a lbino (BALE/ c) mice. When this 
technique was performed on t issue cul tured cells, t hey were seeded in to 
Lab-Tek t issue culture chamber/slides and grown unt il they reached 
semiconfluence. For cytoplasmic staining, t he ce lls were fixed in meth-
a nol a t -2o· c for 10 min, followed by acetone at -2o·c for 10 min; for 
cell surface staining, t hese fixation steps were omitted. The fixed slides 
were incubated 1 h with supernatants from hybridoma cultures diluted 
in PBS (1:1000), containing 2% bovine serum albumin and 0.2% sodium 
azide (PBS/BSA). After washing the s lides 6 t imes, FITC-conjugated 
second antibodies diluted in PBS/BSA (1:50) were used, and incubation 
was for 1 h. After thorough washing, fluorescence was detected using a 
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Leitz Ortholux II microscope. When immunofluorescence was per-
formed on muri ne skin or murine eye, the tissues were dissected from 
5-day newborn mice, frozen in O.C.T. embedding medium , and cut into 
thin sections with a cryostat. These sections were collected on ovalbu -
min -coated glass slides and were used for staining as described above. 
Epitope Mapping 
The epitope mapping experiments shown in Fig 4 were carried out 
using the partia l proteolytic digestion technique of Cleveland et a! 
[21] . Since tyrosinase is extremely res istant to proteolytic degradation, 
10 J.L g of T ,-tyrosinase was heated to 10o•c in 1% sodium dodecyl 
sulfate (SDS) fo r 5 min, then reacted for 60 min at 37•c with va rying 
amounts of VS protease, as noted in the legend to Fig 4. The reactions 
were stopped by the addition of 2-mercaptoethanol and by heating to 
10o· c for 5 min; the peptides were then separated on 12% polyacryl -
amide Laemmli 122] SDS gels, t ransferred to nit rocellulose, and ana-
lyzed fo r antibody binding as deta iled above. 
lmmun.oprecipitation Analysis 
B16 F 10 melanoma cells were grown to semiconfluence in DMEM 
with 10% fetal bovine serum, ant ibiotics, and nonessent ial amino acids: 
Approximately 10 7 of these ce lls were then metabolically labeled for 1 
h at 37•c in the presence of [35S ]methionine, 500 J.L Ci/ ml in methionine-
free DMEM, wi th 10% dia lyzed fetal bovine serum. The cells were then 
harvested wit h trypsin, and solubilized in' 2 ml 1% NP-40/ PBS for 1 h 
at 4•c . The cell extracts were cent ri fuged at 50,000 g for 30 min, and 
the cell -free supernatants were used for immunoprecipitation as fo l-
lows: 5 X 106 dpm 35S-labeled proteins were incubated with 50 J.Ll 
monoclonal antibody supernatant in a total volume of 200 11!, for 90 
min at 37"C, then 1 J.Ll rabbit JgG anti rat IgG was added, and incubated 
for another 60 min at 37•c . One hundred microlite rs of P rotein A 
Sepharose was added, and the incubat ions cont inued fo r a nother 30 
min at room temperature. The immune conjugates were then washed 5 
times wi th PBS/NP-40 and once with water. The specifically immu-
noprecipitated proteins were elu ted with Laemmli SDS sample buffer 
at 10o· c for 5 min, then separated on 7.5% SDS polyacrylamide gels; 
t hese were then incubated in En·'Hance for 15 min, dried, a nd auto ra-
diographed on x-ray film . 
RESULTS 
Although several attempts with different immunization pro-
tocols were made to produce antibodies against t he T 1 and T ., 
forms of tyrosinase, we were never successful in producing ~ 
demonstrable humoral response to these enzymes in rats (data 
not shown). However, after fusion of SP2/0 myeloma cells and 
hyperimmune spleen cells from rats immunized wit h T 4 -tyro-
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FIG 1. Specificity of TMH -1, TMH-2, and TMH-3 monoclonal 
ant ibodies. T,- , T2-, and T,-tyrosinases, which had been isolated from 
816 melanoma, were separated by polyacrylamide ge l electrophoresis 
and blotted to nitrocellulose sheets, as detailed in Materials and M eth-
ods. Proteins separated ident ically and transblotted in each panel were 
as follows. Lane / - Standard proteins (3 J.L g each, molecular weight 
noted on the left; <26 kD migrated at the dye fron t); lane 2-1 J.Lg T,-
tyros inase; lane 3-10 J.Lg T2-tyrosinase; lane 4- 10 J.Lg T d yrosinase. 
The ni t rocellulose sheets were t reated as follows: (A) stained with fast 
green, (B) stained histochemically with dopa, (C- E) reacted wit h 
TMH -1, TMH-2, or TMH-3, respectively, then with peroxidase-con -
jugated ant ibodies, and visualized wi th the diaminobenzidine reaction, 
as deta iled in Materials an.d Methods . 
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sinase, several wells showed positive production of anti-T4-
tyrosinase antibody as determined by ELISA screening (data 
not shown). From 3 different wells, antibody-producing clones 
were obtained by the limiting dilution technique and have been designated TMH-1, TMH-2, and TMH-3. The specificity of 
these 3 monoclonal antibodies is shown in Fig 1. T,- and T 2-
tyrosinases showed strongly positive bands of enzymatic activ-
ity by dopa staining while T 4-tyrosinase stained very faintly at 
the same mobility as T ,-tyrosinase. The monoclonal antibodies 
TMH-1, TMH-2, and TMH -3 showed only a single band of 
reactivity against T, -tyrosinase at the same mobility as the dopa stain of T 4 -tyrosinase. Neither T,-tyrosinase nor T 2-
tyrosinase was recognized by any of the monoclonal antibodies; 
thus, these antibodies bind specifically to T 4 -tyrosinase (T, and 
T 2 tyrosinases were overloaded on the gels deliberately to 
demonstrate the lack of cross-reactivity) . When the electropho-
retic mobility of T 4 -tyrosinase was altered by the removal of 
sialic acid with neuraminidase as previously described [9,11], 
the antibodies continued to react with the electrophoretically 
altered form of the enzyme (data not shown), further showing 
the specificity of the antibody for T,-tyrosinase, as well as 
demonstrating that the epitopes are not dependent on the 
presence of sialic acid. TMH-1 consistently showed higher 
levels of reactivity with tyrosinase at saturating antibody levels 
than did either TMH-2 or TMH-3; this is apparently a reflec-
tion of the reactivities of the epitopes involved. 
Our attempts to detect the presence of T ,-tyrosinase in crude 
homogenates of B16 melanoma cells by this Western immu-
noblot technique were unsuccessful; we have attributed this to 
the fact that tyrosinase represents less than 0.1% of the total 
protein, and thus must be present in too low a concentration 
to be detected. In addition, our experience in other related 
experiments has suggested to us that tyrosinase may bind to 
nitrocellulose in less than an optimal manner (or does not bind 
in an active configuration), since large amounts of enzyme 
needed to be applied to the original polyacrylamide gels to 
demonstrate even the low reactivities in these figures. However, 
A B 
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FIG 2. Purity of immunizing tyrosinase fractions and radioimmu-
noprecipitation of tyrosinase by TMH-1 and TMH-2 antibodies. A, 
Electrophoretic purity of the tyrosinase isozymes used for the immu-
nization of rats; isozymes were purified as detailed in Materials and 
Methods, separated by polyacrylamide gel electrophoresis under non-denaturing conditions, and stained with Coomassie B lue. Lane J- 2 !Lg 
T, tyrosinase; lane 2- 2 !Lg T, tyrosinase; lane 3- 2 11g T 4 tyrosinase. B, Bl6 melanoma cells were labeled for 3 h in vitro with [36S]methio-
nine, the proteins were solubilized, and then immunoprecipitated with 50 JLl culture supernatant (with or without antibodies), as detailed in 
Materials and Methods. The precipitated proteins were separated by SDS polyacrylamide gel electrophoresis, fixed, and then autoradi-
ographed. The samples separated were the following. Lane 4- 14C-labeled standard proteins (molecular weight noted on the left in kilo-
daltons); lanes 5-7-:lhS-Iabeled Bl6 protein extract, immunoprecipi-
tated with 50 11l culture medium, or with 50 11l TMH-1, or TMH-2, 
culture supernatants. 
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FIG 3. Indirect immunofluorescence staining of melanocytes. Mu-
rine melanocytes were examined for localization of TMH-1 monoclonal 
antibody binding by indirect immunofluorescence as detailed in Mate-
rials and Methods. Identical sections were viewed either by phase 
contrast (1, shown on t he left), or by fluorescence (2, shown on the ~igh~) micr~scopy . Bars = 10 11m. Top row: Bl6 melanoma cells grown 
m v1tro. Mtddle row: dorsal skin from 5-day newborn C57Bl/6N mice (SC, stratum corneum; E, epidermis; D, dermis) . Bottom row: eye tissue 
from 5-day newborn C57Bl/6N mice ( V", vitreous chamber; R, retina; C. choroid; S, sclera). 
we have been able to immunoprecipitate metabolically labeled 
tyrosinase with the TMH-1 and TMH-2 antibodies, as shown 
in Fig 2B (TMH-3 was nonprecipitating). The molecular weight 
of the precipitated antigen was 70,000, which is consistent with 
the established mass of mammalian Tctyrosinase [6,23,24]. 
When the 3 monoclonal antibodies TMH-1, TMH-2, and 
TMH-3 were used for indirect immunofluorescent staining of 
various pigmented and unpigmented cells, only pigmented 
melanocytes in the murine epidermis, retina, and B16 mela-
noma were stained by each of 3 monoclonal antibodies. Fig 3 
shows the specificity of this reaction; specimens are shown on 
the left ?f the figure as they appear under phase contrast, and 
on the nght by fluorescence microscopy. On the other hand, in 
the nonpigmented tissues examined, such as the K1735 mela-
noma, 112 fibrosarcoma, albino epidermis, albino eye tissue, 
and r~t fibroblasts, there was no reactivity with the monoclonal 
antibodies (data not shown) . The staining of pigmented tissues 
by these antibodies further revealed that the antigen could be detected only cytoplasmically; nothing was stained on the cell 
surface, as would be expected from the known subcellular 
distribution patterns of tyrosinase [25,26). At higher magnifi-
cations, the particulate nature of the fluorescent stain was 
often evident, as was the perinuclear distribution of the anti-
body localization. 
In order to further characterize the specificity of these mono-
clonal antibodies, epitope mapping experiments were carried 
out, as shown in Fig 4. Although fast green staining of the 
peptides showed that many proteolytically derived fragments 
ofT,-tyrosinase were present on the nitrocellulose sheets, none 
of these digested bands was recogni?:ed by either the TMH-2 
or TMH-3 antibodies. The TMH-1 monoclonal antibody and a 
rabbit antityrosinase polyclonal antibody were able to bind to 
several of the bands. These results indicate that the epitope(s) 
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FIG 4. Epitope mapping of TMH-1, TMH-2, and TMH-3 monoclo-
nal antibodies by partial proteolysis of tyrosinase. Ten micrograms of 
T 4 -tyrosinase was digested by VB protease at the concentrations noted 
below, then separated by SDS polyacrylamide gel electrophoresis on 
12% gels, and transblotted to nitrocellulose sheets, as detailed in 
MateriaL~ an.d Methods. Proteins run identically in each panel were as 
follows. Lan.e !- Standard proteins (5 11 g, molecular weight noted in 
t he margin) ; lan.e 2-T, -tyrosinase, digested with 30 ng/ml VB protease; 
lane 3- T,-tyrosinase, digested with 300 ng/ ml VB protease; lan.e 4-
T,-tyrosinase, digested with 3 J.Lg/ ml VB protease. The nitrocellulose 
sheets were treated as follows: (A) stained with fast green (B- E) were 
reacted with rabbit IgG antityrosinase, TMH-1, TMH-2, or TMH-3, 
respectively, then with peroxidase-conjugated antibodies, and finally 
visualized with the diaminobenzidine reaction , as detailed in Materials 
and Methods. 
recognized by the TMH-2 and TMH-3 were destroyed quanti-
tatively either by the V8 protease digestion or by denaturation 
with SDS, and further show that the TMH-1 antibody recog-
nizes a different epitope from the TMH-2 and TMH-3 antibod-
ies. In separate experiments utilizing ELISA, it was shown that 
treatment with V8 protease under identical conditions did not 
alter the reactivities (or lack thereof) of the TMH-1, TMH-2, 
or TMH-3 antibodies with the T1, T z, or T. isozymes of tyro-
sinase (data not shown). 
To determine the immunoglobulin subclass of the TMH-1, 
TMH-2, and TMH-3 antibodie~, ELISA was utilized. Only 
antirat IgG2• antibody bound to these monoclonal antibodies, 
as shown by the data in Table I. The identification of the 
TMH-1 TMH-2 and TMH-3 antibodies as IgGz. was con-
firmed by Oucht~rlony double-diffusion analysis; thick precip-
itin lines were formed only between wells containing antirat 
IgG2• antibody and wells containing either the TMH-1, TMH-
2 , or TMH-3 antibodies (data not shown). 
DISCUSSION 
We attempted to isolate hybridomas that produced monoclo-
nal antibodies against T 1- and T 2-tyrosinases several times 
during these studies, using different immunizing protocols, but 
without success. The apparent reason that we did not succeed 
was that the titer of anti-T1- and anti -T2-tyrosinase antibodies 
could not be elevated even after multiple injections of the 
enzymes at various do~es into rats. This suggests that at least 
the precursor forms of tyrosinases are highly conserved en-
zymes which have little or no antigenicity toward closely related 
species. 
The monoclonal antibodies TMH-1, TMH-2, and TMH-3 
that we did produce bind to T 4 -tyrosinase specifically, and do 
not cross-react with T 1- or T 2-tyrosinase (Fig 1) . Previously, 
t here had been no way to distinguish between T1-tyrosinase 
and T 4 -tyrosinase which had been solubilized from melano-
s omes by trypsin or by ionic detergents [6,12] . Although the T1 
and T 4 forms of tyrosinase are identical by kinetic, chemical, 
and electrophoretic criteria, it is now possible to distinguish 
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TABLE I. Immunoglobulin. subclass determination. of TMH-1, TMH-2, 
an.d TMH-3 
Protein bound to 
Peroxidase activity (A 492)" 
ELISA plate SP2/0 TMH-1 TMH-2 TMH-3 medium 
Buffer .00 .00 .00 .00 
.03 .00 .00 .00 
.05 .00 .00 .00 
Antirat IgA 300 ng .06 .05 .05 .05 
60 ng .07 .04 .04 .03 
12 ng .07 .02 .04 .03 
Antirat IgE 300 ng .06 .02 .03 .00 
60 ng .09 .00 .00 .00 
12 ng .09 .00 .00 .00 
Antirat IgG1 300 ng .01 .03 .02 .02 
60 ng .02 .01 .00 .00 
12 ng .01 .01 .02 .01 
Antirat IgGz. 300 ng .05 .70 .69 .64 
60 ng .06 .62 .66 .53 
12 ng .04 .52 .46 .36 
Antirat IgG,b 300 ng .06 .03 .03 .02 
60 ng .OB .02 .02 .00 
12 ng .07 .02 .02 .01 
Antirat IgG.., 300 ng .04 .03 .03 .02 
60 ng .06 .00 .00 .00 
12 ng .06 .02 .01 .01 
Antirat lgM 300 ng .04 .03 .02 .00 
60 ng .05 .00 .00 .00 
12 ng .06 .01 .OB .00 
• Details of these assays are as described in Materials an.d Methods. 
these forms by immunologic means. This infers that T4-tyro-
sinase differs from T1 -tyrosinase, perhaps with respect to con-
formational changes or unknown further posttranslational 
modifications which are recognized by these immunologic 
probes. Work is currently under way to characterize the im-
munologic determinants on T4-tyrosinase that are recognized 
by these antibodies. 
The TMH-1, TMH-2, and TMH-3 antibodies bind not only 
to the solubilized form of T.-tyrosinase, but also to the melan-
osome-bound native enzyme, as judged from the positive im-
munofluorescent staining of pigmented melanocytes in vivo 
and in vitro (Fig 3). The specificity of these antibodies is 
absolute since not only are other, nonmelanocytic murine cells 
not recognized, but even unpigmented melanocytes were not 
identified, in the K1735 amelanotic melanoma, and in albino 
skin and eye. 
It can also be seen in Fig 3 that the B16 melanoma cells 
growing in vitro are uniformly reactive with the antibodies, 
since they would all be expected to be engaged similarly in 
tyrosinase synthesis and melanin production. However, it can 
also be readily seen in Fig 3 that t he choroid and retinal layers 
of the eye are not uniformly stained. We interpret this t o 
indicate that not all melanocytes in these tissues are engaged 
in active melanogenesis. Since tyrosinase synthesized in the 
melanocyte and subsequently incorporated into t he melano-
some normally begins immediate synthesis of melanin, and 
since the melanin might be expected to rapidly occlude the 
epitope sites of tyrosinase, it seems reasonable to expect that 
only melanocytes actively synthesizing tyrosinase will be rec-
ognized by these antibodies, and that once enzyme expression 
is turned off, reactivity will be lost. The kinetics of these 
reactivities, and the time course variation of antibody reactivity 
in response to environmental changes such as ultraviolet radia-
tion stimulation and hormonal variation, might provide new 
insights into the mechanics of the regulation of pigment pro-
duction at the enzymatic level in subsequent studies. 
The immunoglobulin subclass of all 3 monoclonal ant ibodies 
is identical (lgG2. ), but the TMH-1 antibody obviously recog-
nizes a different epitope than does TMH-2 or TMH-3, judging 
from the epitope mapping experiments (Fig 4) . As we did not 
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get adequate data on epi tope specificity us ing t his method wi t h 
'TMH -2 or TMH-3 antibodies, it remains a possibili ty t hat Lhey 
a re t he same antibody, although t hi s cannot be determined at 
p rese nt. Since the a moun t of di gested ty rosinase was co ns id -
e rable, judging from the dens ity of fasL gree n sta ining of pep-
t ides on t he t ransblotted ni t rocellulose sheets, the lack of 
reactivity of TMH -2 and TMH-3 seen in t he epi tope mapp ing 
experimenLs is not due to limi t ing quanLities o f peptides, but 
rather must resul t from t he destruction of t he epitope site 
under t hese expe rime nta l conditions. This could be due to t he 
changing of t he te rt iary structure of Lyrosinase by t he SDS 
de naturation, or pe rh aps results from the immediaLe proteo lytic 
cleavage of t h e ep iLope by V8 protease digestion. 
Antibodies wi t h appa ren t spec ific ity to malign an t melano-
cytes have been desc ribed by othe r groups, a lt hough with more 
detailed sc reenin g, most if not a ll of t hese an t ibod ies have been 
found to be directed aga inst feta l o r cross- reacting t umor an -
t igens (for review see [27]). Mattes et a ! [28) have recently 
defined a pigmentation -associated differentiation antigen us ing 
a n antiserum from a patient wi t h malignant mela noma. This 
an tige n a lso cross-reacts with normal mela nocytes, a nd recog-
ni zes a protein of 70,000 molecula r weight; however, t hi s a n t i-
ge n is not tyrosinase [28], no r has t he functio n a l signi fica nce 
of t he prote in bee n iden t ified. 'The complete specificity of t he 
Mattes et al\ 28] antigen awaits furt he r sc reening. Our antibody 
is directed aga inst a know n, pigmentation-specific en zymatic 
prote in , ty rosinase , that is common to me la nocytes both in t he 
no rma l a nd t ransfo rmed states. Polyclona l a ntibodies aga inst 
ma mma lia n tyrosinase have been produced by seve ral labo ra -
t ories [1 3- 16] ; t hese reagents (where tested) c ross- reacted wi t h 
a ll t he isozy mes. Whethe r a ny of t hese a nt ibodies have absolute 
specificity fo r mammalian tyrosinase has not yet been com -
p letely reso lved , nor have attempts been made to use a ny of 
t hose po lyclonal a ntibodies as probes fo r t he immunofluores-
cent identification of melanocyies . 
· 'The presence of demonstrab le tyrosi nase activity [1 4,29- 31] 
coup led with t he lac k of pigment fo rmation in a lbino a nimals 
has been pe rpl ex ing. The data in t hi s pape r show t hat a lt hough 
tyros inase may be sy nt hesized by mela nocytes in a lbino a ni -
mals, whateve r posttranslat ional mod ifications a re requ ired to 
process the precursor forms of the en zy me to t h e mature, 
enzymatica ll y act ive T.,-ty rosinase do not take place . This 
step(s) may we ll turn out to be t he molecular s ite of act ion of 
t he a lbino locus; as ment ioned above, work is under way to 
determine the nature of the epitope sites recognized by these 
monoclona l a n t ibodies, suc h info rmation should provide fur -
t he r clues as to the metabolic lesion (s) respons ible for a lbini sm. 
In summ a ry t hen , we have succeeded in producing monoclo -
na l a ntibodies specifi cally directed against the mature, T, form 
of tyrosi nase. The lack of c ross- reactivity with t he precurso r 
fo rms of tyr osinase suggest t hat fur t he r posttrans lationa l mod-
ifications of tyrosi n ase occur , othe r than just aggregation with 
othe r rne lanosomal proteins . These antibodies are use ful fo r 
ident ifying ty rosinase-conta ining cell s such as t he Bl6 mela -
noma, no rm al murine ep idermal mela nocytes, a nd murine ret-
ina l mela nocytes by immunoflu orescent sta ining. These a nt i-
bodies do not sta in unpigmented ce ll s such as fibrosarcom a or 
ra t ftbroblasts, or surroundin g epiderma l ce ll s such as ke ratin -
ocytes, a nd do not even recognize unpi gmented mela nocytes. 
We have recentl y determined that these a ntibodies cross-react 
specifica lly with human pigmented cells, which furth er re in -
forces the idea of t he hi ghly conserved nature of ty rosinase in 
mammals . These monoclona l a n t ibodies should prove ex-
t remely importa nt not only fo r t he furt her cha racterization of 
tyrosinase process ing in mela nocytes, but a lso as a specific, 
sens itive immunohistochemical too l for t he identification of 
melanin -synthesizing melanocytes. 
T he author!; wish to acknowledge the welcome assistance of Dr. 
Stephen Katz, Dr . ,Jo David Fine, Ms. Patricia Fox, and Mr. .Jay Linton 
in this swdy. 
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